Companies like Google and. Amazon are front runners in ... the World Health Organisation and an agency of the European U
HOW TO MAKE DATA DRIVEN BUSINESS DECISIONS The introduction of computers transformed businesses and organisations. Data is everywhere and is leading next phase of transformation. Companies like Google and Amazon are front runners in making data driven decisions both in terms of how they manage themselves and their customers. More and more companies strive to emulate their success. However, there are dangers in trying to copy and paste their methods and processes without understanding data science and the risks. Every decision that a manager makes involves risk taking. Organisations increasingly recognise that their decisions need to be substantiated hence the rise of data and data science in decision making processes. Managers are often left feeling overwhelmed with trying to get on top of understanding their data whilst staying ahead of their competition. Left unabated things can very quickly get out of control and lead to organisational paralysis. Leaders who can drive and implement the best data science practices will ultimately have the best results. This means understanding “what data science is” and building processes that gets the best from their people. Investing in people’s knowledge and skills is a must given the fast-paced nature of developments in data science along with building a culture of openness and transparency to minimise and eliminate risks. Being aware of your weaknesses before your competition or regulators is the strongest position you can put yourself in. Embrace data science and embrace the challenges and rewards it can bring.
Saghir Bashir. Expert in Data Science, Statistics and Programming, he has over 25 years of international experience, both in public and private sector. Along his diverse professional path, he has designed and managed strategic & implementation projects, concerning Data Science and Statistic applied to organizational context, in companies such as: Janssen, Novartis, Astrazeneca, Angen e UCB Pharma; as well as an agency of the World Health Organisation and an agency of the European Union. Namely, in the study and development of the project’s methodology, collection of data, statistics/ data
analysis, reporting and data interpretation, according to the best scientific practices, international guidelines and the up to date methods especially in statistics, risk assessment and systematic reviews. He is the founding member and CEO of Ilustat. He is frequently invited to deliver numerous presentations around the world. He has a PhD in Biostatistics and Epidemiology (Cambridge University, UK), Diploma in Mathematical Statistics and B.Sc. Mathematics (Statistics).
